Cite
HARVARD Citation
Ogungbenro, K. et al. (2018). Dose Rationalization of Pembrolizumab and Nivolumab Using Pharmacokinetic Modeling and Simulation and Cost Analysis. Clinical pharmacology & therapeutics. 103 (4), pp. 582-590. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ogungbenro, K. et al. (2018). Dose Rationalization of Pembrolizumab and Nivolumab Using Pharmacokinetic Modeling and Simulation and Cost Analysis. Clinical pharmacology & therapeutics. 103 (4), pp. 582-590. [Online].